The heparin binding properties of heparin cofactor II suggest an antithrombin-like activation mechanism.
about
Thrombin inhibition by the serpinsStructure of native protein C inhibitor provides insight into its multiple functionsHeparin binds lamprey angiotensinogen and promotes thrombin inhibition through a template mechanismGlycosaminoglycan-binding properties and kinetic characterization of human heparin cofactor II expressed in Escherichia coliSucrose octasulfate selectively accelerates thrombin inactivation by heparin cofactor IIThe murine orthologue of human antichymotrypsin: a structural paradigm for clade A3 serpins.The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand.Dynamic changes in cervical glycosaminoglycan composition during normal pregnancy and preterm birth.A Hexasaccharide Containing Rare 2-O-Sulfate-Glucuronic Acid Residues Selectively Activates Heparin Cofactor II.Fluorescent reporters of thrombin, heparin cofactor II, and heparin binding in a ternary complex.Serpins in thrombosis, hemostasis and fibrinolysisMolecular engineering of glycosaminoglycan chemistry for biomolecule delivery.Approaches to prevent bleeding associated with anticoagulants: current status and recent developments.Cooperative heparin-mediated oligomerization of fibroblast growth factor-1 (FGF1) precedes recruitment of FGFR2 to ternary complexes.Antiangiogenic forms of antithrombin specifically bind to the anticoagulant heparin sequence.Heparin Mimetics: Their Therapeutic Potential.Inhibitory activity of the Drosophila melanogaster serpin Necrotic is dependent on lysine residues in the D-helix.Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer.
P2860
Q27006905-04E4D63D-15ED-4584-8534-D8BC8B5914CBQ27643980-C500134C-7DC5-4DDE-AB8D-AE942D3281ACQ27728134-2191B758-E99B-4699-A254-4BD3EDD8FAACQ33645142-15384B95-91DA-4286-A84B-8A02C8659E38Q33707130-38CD4560-9889-4ADC-BFA3-7CAF7DE66083Q34448263-E7C18FFA-DF07-420F-A174-3C4735E1E3D8Q34621763-1333F020-9563-418A-A71A-23F07540BC25Q36049822-E26F4C5A-D217-4DEC-A55A-0E7B06E4D3ECQ36260763-E11594D5-7060-473D-B797-5BB6650AF7A7Q36288526-2009BF61-F4F8-460F-9018-4525818C2139Q36884340-4DA3E1BC-E786-4590-AE28-1B319237991AQ38152204-8B9C55C0-72D1-4289-96AC-9B0F8430C488Q39456319-9FF420CC-C526-43EA-B4F0-6152CF2B3A44Q39900683-298CC6EB-110F-4880-BE46-2554A6C11C89Q42129117-D79DBCE1-7E38-4E23-BE51-A66EDBC905C7Q47159791-ABF52A67-06AA-4B70-97F5-31A240606B9DQ52670119-4992C517-74B5-4D72-A867-A759F8A751EEQ55058467-9B9B08C6-42DB-4399-AF5A-1DD0AF950441
P2860
The heparin binding properties of heparin cofactor II suggest an antithrombin-like activation mechanism.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
The heparin binding properties ...... bin-like activation mechanism.
@en
The heparin binding properties ...... bin-like activation mechanism.
@nl
type
label
The heparin binding properties ...... bin-like activation mechanism.
@en
The heparin binding properties ...... bin-like activation mechanism.
@nl
prefLabel
The heparin binding properties ...... bin-like activation mechanism.
@en
The heparin binding properties ...... bin-like activation mechanism.
@nl
P2093
P2860
P356
P1476
The heparin binding properties ...... bin-like activation mechanism.
@en
P2093
Denis O'Keeffe
James A Huntington
John Gallagher
Nijole Gasiunas
Steven T Olson
Trevor P Baglin
P2860
P304
50267-50273
P356
10.1074/JBC.M408774200
P407
P577
2004-09-15T00:00:00Z